RESTATEMENT (Tables)

9 Months Ended

Jun. 30, 2020

RESTATEMENT (Tables)

Schedule of balance sheet

	June 30, 2020
BALANCE SHEET	PREVIOUSLY REPORTED			ADJUSTMENT		RESTATED
Finance lease right of use assets	$	12,367,947		$	1,873,351	$	14,241,298
Total assets		42,034,867			1,873,351		43,908,218
Accumulated deficit		(378,329,567	)		1,873,351		(376,456,216	)
Total stockholders' equity		19,014,940			1,873,351		20,888,291
Total liabilities and stockholders' equity		42,034,867			1,873,351		43,908,218

Schedule of statement of operation

	Nine Months Ended June 30, 2020
STATEMENT OF OPERATIONS	PREVIOUSLY REPORTED			ADJUSTMENT			RESTATED
Research and development expenses	$	12,511,830		$	168,600		$	12,680,430
Total operating expenses		20,901,651			168,600			21,070,251
Operating loss		(20,371,545	)		(168,600	)		(20,540,145	)
Net loss		(24,707,557	)		(168,600	)		(24,876,157	)
Net loss available to common shareholders		(24,729,291	)		(168,600	)		(24,897,891	)
Net loss per share - basic and diluted	$	(0.68	)				$	(0.69	)

	Three Months Ended June 30, 2020
STATEMENT OF OPERATIONS	PREVIOUSLY REPORTED			ADJUSTMENT			RESTATED
Research and development expenses	$	3,912,870		$	56,200		$	3,969,070
Total operating expenses		7,105,273			56,200			7,161,473
Operating loss		(6,909,399	)		(56,200	)		(6,965,599	)
Net loss available to common shareholders		(10,220,779	)		(56,200	)		(10,276,979	)
Net loss per share - basic and diluted	$	(0.27	)				$	(0.27	)